Description
Recombinant monoclonal antibody to VEGF. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the therapeutic antibody Bevacizumab. This chimeric human Fab fragment antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
VEGF
Target Alias Names
ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
Isotype/Mimetic
Fab fragment
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression